La Agencia Estadounidense de Alimentos y Medicamentosha aprobado el medicamento de terapia génica denominado KRESLADI™ (marnetegragene autotemcel) de la empresa Rocket Pharma para el tratamiento de...
The SICC Innvierte fund of CDTI Innovación invests in InceptionBio, a fund aimed at promoting the creation of biotechnology companies and the development of early-stage technology transfer projects.
The Liver vascular biology research group at IDIBAPS, in a paper published in the journal BMC Medicine, has presented three new hepatic biomarkers capable of predicting patients’ clinical progressio...
Changing CDMO late in development is not always a warning sign. Sometimes it is the right decision. But it should be managed as a strategic move, not an administrative transfer.